Related Experiment Video

Updated: Aug 8, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

[Immunogenicity and safety of Di-Te-Ki-Pol vaccine "SSI" in Danish infants]

E Lyngholm1, A F Gyhrs, S M Bang

  • 1Medicinsk afdeling, Statens Serum Institut, København.

Ugeskrift for Laeger
|September 12, 2000
PubMed

Insights

A new tetravalent DTaP-IPV vaccine demonstrated safety and effectiveness in children. It showed comparable local reactions and adverse events to existing vaccines, with a superior pertussis toxin response.

Area of Science:

  • Pediatric Vaccinology
  • Immunology
  • Public Health

Background:

  • Current vaccination schedules involve multiple injections.
  • Evaluating combined vaccines can simplify immunization protocols.
  • Assessing immunogenicity and safety of novel vaccine formulations is crucial.

Purpose of the Study:

  • To compare the safety and immunogenicity of a tetravalent DTaP-IPV vaccine against the existing Danish vaccination regimen.
  • To evaluate local reactions, febrile episodes, and serious adverse events.
  • To assess antibody responses to diphtheria, tetanus, polio, and pertussis.

Main Methods:

  • A randomized study involving 270 children at their five-week routine examination.
  • Children received either the tetravalent DTaP-IPV vaccine or the DT-IPV plus whole-cell pertussis vaccine.
  • Monitoring for adverse events, local reactions, and antibody levels post-vaccination.

Main Results:

  • No serious vaccine-related adverse events, including hypotonic-hyporesponsive episodes, were observed.
  • Local reactions, febrile episodes, and crying were similar between the two vaccine groups.
  • All children achieved protective antibody levels for polio, diphtheria, and tetanus.
  • The tetravalent DTaP-IPV vaccine elicited a significantly better response to pertussis toxin.

Conclusions:

  • The tetravalent DTaP-IPV vaccine (Di-Te-Ki-Pol vaccine
  • SSI") is safe and immunogenic in infants.
  • This combined vaccine offers a potentially simplified and effective immunization strategy.
  • The investigational vaccine demonstrated an enhanced immune response to pertussis.

More Related Videos

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection

Published on: September 1, 2023

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...